[2] provided compelling evidence that anti-nephrin autoantibodies are associated with disease activity in both MCD and recurrent FSGS post-kidney transplantation, suggesting that autoantibody profiles could serve as potential biomarkers for disease monitoring and prognosis. This evidence concerns the gene NPHS1 and focal segmental glomerulosclerosis.